ThinkCyte’s mission is to provide scientists and biomedical professionals with a transformational single-cell technology that accelerates biological discoveries and enable the development of novel treatments and diagnostics through the integration of advanced hardware, machine learning, and biotechn... Read more
View all
Odyssey Therapeutics
Cambridge, United States · Series B
Kyverna Therapeutics
Emeryville, United States · Series B
Jnana Therapeutics
Boston, United States · Series C
Werewolf Therapeutics
Cambridge, United States · IPO
Scribe Therapeutics
Alameda, United States · Series B
Checkerspot
Oakland, United States · Series C
Goldfinch Bio
Cambridge, United States · Series B
Arbor Biotechnologies
Cambridge, United States · Series B
Lumos Pharma
Austin, United States · IPO
MOMA Therapeutics
Cambridge, United States · Series B
Synthekine
Menlo Park, United States · Series C
Prilenia
Herzliya, Israel · Series B